Name Koen Andries | ||
 | ||
Koen andries team drug against multidrug resistant tuberculosis
Koen Andries is a Belgian Janssen Pharmaceutica and professor at the University of Antwerp. In 2005 he and his team published a discovery about a new di-Aryl-Quinoline-based drug (R207910) which promises a shorter and simpler treatment for Tuberculosis (TB).
Contents
Koen andries team drug against multidrug resistant tuberculosis
Career
He graduated as a Veterinarian and obtained a PhD at the University of Ghent (Ghent, Belgium) in 1975. He continued his career at the university until 1982, when he started working at Janssen Pharmaceutica in Beerse until 2004. In 2004 he continued his research at Tibotec in Mechelen.
Recognition
References
Koen Andries Wikipedia(Text) CC BY-SA